The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Gemcitabine re-challenge in metastatic soft tissue sarcoma: A therapeutic option for selected patients.
 
Ana Sebio
No Relationships to Disclose
 
Georgios Antoniou
No Relationships to Disclose
 
Khin Thway
No Relationships to Disclose
 
Aisha Miah
No Relationships to Disclose
 
Shane Zaidi
No Relationships to Disclose
 
Charlotte Benson
No Relationships to Disclose
 
Winette TA van der Graaf
No Relationships to Disclose
 
Robin Lewis Jones
Consulting or Advisory Role - Adaptimmune; Blueprint Medicines; Daiichi Sankyo; Deciphera; Eisai; Immodulon Therapeutics; Immune Design; Lilly; Merck Serono; Morphotek; PharmaMar; TRACON Pharma
Research Funding - GlaxoSmithKline (Inst)
Travel, Accommodations, Expenses - PharmaMar